Recruiting Multiple Myeloma Studies in Ramat Gan
About Multiple Myeloma Clinical Trials in Ramat Gan
Multiple myeloma is a cancer of plasma cells in the bone marrow that produce abnormal antibodies. It can cause bone damage, kidney problems, and immune deficiency. Treatments have advanced significantly with proteasome inhibitors, immunomodulatory drugs, and CAR-T cell therapy.
There are currently 1 multiple myeloma clinical trials recruiting participants in Ramat Gan, . These studies are seeking a combined 440 participants. Research is being sponsored by AbbVie. Clinical trial participation is free and participants receive study-related medical care at no cost.
Multiple Myeloma Clinical Trials in Ramat Gan — FAQ
Are there multiple myeloma clinical trials in Ramat Gan?
Yes, there are 1 multiple myeloma clinical trials currently recruiting in Ramat Gan, . Browse the studies on this page to find one that fits.
How do I join a clinical trial in Ramat Gan?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Ramat Gan research site will contact you about next steps.
Are clinical trials in Ramat Gan free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Ramat Gan studies also compensate for your time and travel.
What multiple myeloma treatments are being tested?
The 1 active trials in Ramat Gan are testing new therapies including novel drugs, biologics, and treatment approaches for multiple myeloma.
Data updated March 2, 2026 from ClinicalTrials.gov